Checkpoint Therapeutics, Inc.
CKPT · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $41 |
| % Growth | – | – | -100% | – |
| Cost of Goods Sold | $0 | $16,809 | $6,366 | $4,480 |
| Gross Profit | $0 | -$16,809 | -$6,366 | -$4,439 |
| % Margin | – | – | – | -10,826.8% |
| R&D Expenses | $3,788 | $16,809 | $6,366 | $4,480 |
| G&A Expenses | $7,361 | $12,020 | $3,358 | $2,234 |
| SG&A Expenses | $7,361 | $12,020 | $3,358 | $2,234 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11,149 | $28,829 | $9,724 | $6,714 |
| Operating Income | -$11,149 | -$28,829 | -$9,724 | -$6,673 |
| % Margin | – | – | – | -16,275.6% |
| Other Income/Exp. Net | -$63 | -$71 | -$1 | $3 |
| Pre-Tax Income | -$11,212 | -$28,900 | -$9,725 | -$6,670 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11,212 | -$28,900 | -$9,725 | -$6,670 |
| % Margin | – | – | – | -16,268.3% |
| EPS | -18.74 | -0.7 | -0.23 | -0.18 |
| % Growth | -2,577.1% | -204.3% | -27.8% | – |
| EPS Diluted | -18.74 | -0.7 | -0.23 | -0.18 |
| Weighted Avg Shares Out | 598 | 39,674 | 43,152 | 36,526 |
| Weighted Avg Shares Out Dil | 598 | 39,674 | 43,152 | 36,526 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $2 | $2 | $3 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | -$43 | $0 | $0 |
| EBITDA | -$11,149 | -$28,829 | -$9,724 | -$6,673 |
| % Margin | – | – | – | -16,275.6% |